15 March 2026
ACACIA RESEARCH CORP
10-K / March 12, 2026
10-K / March 17, 2025
10-K / March 12, 2026
Acacia Research Corporation
Overview
Acacia Research Corporation is a multi-segment holding company that acquires and operates businesses across public and private markets and multiple industries, including industrial, energy, and technology. The company focuses on durable free cash flow, scale opportunities, and value creation through ownership and operational improvement. Acacia builds platforms from acquisitions, with flexibility to grow via organic initiatives and bolt-on transactions and to monetize platforms over time.
Business model and operating approach
- Targets undervalued opportunities across industries and capital structures.
- Uses a broad capital base and transaction expertise to structure investments.
- Applies hands-on operating oversight rather than relying on purely financial ownership.
- Pursues platform-building acquisitions and retains optionality for exits or monetization.
People and governance
- Employees (as of December 31, 2025): 986 full-time employees and 76 contractors.
- Parent company: 13 full-time, 2 contractors
- Intellectual Property Operations: 7 full-time, 1 contractor
- Industrial Operations: 128 full-time, 0 contractors
- Energy Operations: 45 full-time, 0 contractors
- Manufacturing Operations: 793 full-time, 73 contractors
- Ownership and control:
- Starboard Value LP and affiliates are the controlling shareholder.
- As of March 9, 2026, Starboard controlled approximately 63.4% of voting power.
- The company is a “controlled company” under Nasdaq rules, with governance provisions tied to Starboard (for example, certain board independence requirements are in place through May 12, 2026, and board size is capped during that period).
- Related-party arrangements:
- A recapitalization completed in 2022–2023 restructured Starboard’s investment; Series A Preferred Stock, Series B Warrants, and Senior Secured Notes from prior financings are no longer outstanding.
- Services Agreement with Starboard executed in December 2023 for specified services on an expense-reimbursement basis; the Audit Committee provides oversight and the agreement includes limited liability provisions.
Segment spotlight: Intellectual Property Operations (IP)
- Business: Licensing, enforcement, and development of patent portfolios for licensing and enforcement.
- Scale and activity:
- More than 1,600 license agreements executed (as of December 31, 2025).
- Licensing programs cover nearly 200 patent portfolios.
- Portfolio additions include Wi‑Fi 6 (2021) and a Wi‑Fi 7 ESS portfolio (2025), among others added in 2020.
- Financial and partner returns:
- Gross licensing revenue ≈ $1.9 billion (as of December 31, 2025); $898.2 million returned to patent partners.
- Over the five calendar years ending December 31, 2025: gross licensing revenue ≈ $282.6 million; $87.3 million returned to patent partners.
- Risks and disclosures:
- Ongoing enforcement, licensing, and prosecution activities are core to the segment.
- IP litigation and enforcement costs can be substantial, and patent law and regulatory changes affect the business.
Segment spotlight: Energy Operations (Benchmark)
- Investment and ownership:
- Acacia holds approximately a 73.5% equity interest in Benchmark Energy II, LLC (Benchmark) following transactions in 2023–2024.
- November 13, 2023: Acacia invested $10.0 million to acquire a 50.4% equity interest in Benchmark.
- April 17, 2024: Acacia contributed $59.9 million of Benchmark’s Revolution-related funding as part of acquisitions completed by Benchmark; remaining funding provided by debt and other investors.
- Geography and assets:
- Operations concentrated in the Anadarko Basin region (Western Oklahoma and the Texas panhandle).
- As of December 31, 2025: operated assets include 554 gross wells (474 net); non-operated assets include an average 10% working interest in 82 gross wells (8 net), including Revolution assets.
- Production, acreage, and reserves:
- 2025 production totaled 2,081 Mboe (approximately 5.7 Boe per day).
- Acreage (Anadarko Basin, 2025 energy data): developed 1,174 gross / 149 net; undeveloped 123 gross / 9 net; total 1,297 gross / 158 net.
- Proved reserves (Benchmark, 2025, CGA): crude oil 7,631 MBbl; NGLs 85,500 MBbl; natural gas 11,122 MMcf; total 33,003 MBoe (68% proved developed).
- Proved developed reserves: 22,354 MBoe; proved undeveloped reserves: 10,649 MBoe.
- Standardized measure of discounted future net cash flows: approximately $205.102 million (as of December 31, 2025).
- Risk and development:
- Benchmark’s production is hedged to manage price risk, but hedging does not cover all production due to facility and credit facility constraints.
- Exposures include commodity price volatility, drilling and completion costs, inflation, regulatory changes, and access to capital.
- Benchmark has development plans for undrilled locations and spudded its first horizontal development well in December 2025, with production expected in early 2026.
Segment spotlight: Industrial Operations (Printronix)
- Acquisition: Printronix acquired in October 2021.
- Business: Manufacturer and distributor of industrial impact (line matrix) printers, consumables, and related services, with manufacturing, configuration, and distribution sites in Malaysia, the U.S., Singapore, China, and the Netherlands, and global sales and support.
- Strategic direction: Transitioning revenue mix toward higher-margin consumables (ink cartridges and specialty ribbons) and emphasizing recurring services and consumables revenue over lower-margin printer hardware.
- Revenue mix:
- Printronix expects roughly 56% of revenue for the fiscal year ending March 31, 2026 to come from consumable supplies.
- Operational considerations: International exposure introduces currency, regulatory, and supply-chain risks; the business depends on channel partners and faces potential supplier concentration.
Segment spotlight: Manufacturing Operations (Deflecto)
- Acquisition: Deflecto Purchaser acquired Deflecto Acquisition, Inc. on October 18, 2024 for cash consideration of $103.7 million, funded by a secured term loan of $48.0 million and cash on hand; part of the purchase price is held in escrow.
- Business: Specialty manufacturer serving commercial transportation, HVAC, and office markets.
- Operations: Corporate and manufacturing sites in the United States, United Kingdom, Canada, and China.
- Financial and operational notes: The acquisition includes financing and working capital arrangements; the business faces regulatory and cost pressures, including inflation and tariffs.
Segment spotlight: Life Sciences Portfolio
- Original portfolio: 18 investments in public and private life sciences companies acquired in June 2020 for approximately $282 million.
- Monetization and current holdings:
- Proceeds received through December 31, 2025: approximately $564.1 million.
- Remaining investments valued at approximately $25.7 million (as of December 31, 2025).
- Notable actions:
- January 19, 2024: Sold 33,023,210 shares of Arix Bioscience PLC for $57.1 million and no longer holds Arix shares.
- Ongoing activities include royalties and milestone payments from certain portfolio companies.
Transactions and capital strategy
- Recapitalization in 2022–2023 and the relationship with Starboard are central to Acacia’s capital structure and strategic sourcing.
- The December 2023 Services Agreement with Starboard enables certain services on an expense-reimbursement basis, with Audit Committee oversight.
- The company sources and structures opportunities across public and private markets, including founder-owned businesses, carve-outs, and platform-building acquisitions.
Financial and operating highlights
- IP licensing:
- Gross licensing revenue ≈ $1.9 billion (as of December 31, 2025); $898.2 million returned to patent partners.
- For the five calendar years ending December 31, 2025: gross licensing revenue ≈ $282.6 million; $87.3 million returned to patent partners.
- Profitability:
- The company has recorded losses historically; it reported profitability in 2023 and 2025 and a loss in 2024.
- People and structure:
- Consolidated workforce of 986 full-time employees and 76 contractors, with the segment breakdown listed above.
- Corporate governance:
- Starboard controls a majority of voting power (approximately 63.4% as of March 9, 2026), creating potential conflicts of interest related to control.
- The company has not elected certain Nasdaq controlled-company exemptions at the time of the referenced filing.
- Operational risks:
- IP operations depend on patent portfolios and enforcement activities; litigation and regulatory changes affect outcomes.
- Energy operations face commodity price risk, development risk, hedging limitations, debt covenant considerations, and geographic concentration.
- Industrial and manufacturing operations face customer and supplier concentration, inflation, tariffs, currency exposure, and supply-chain dependencies.
Notable milestones
- Benchmark development and the Revolution acquisition closed in 2024, increasing Acacia’s ownership and asset base in energy operations.
- IP portfolio additions occurred across 2020–2025, including Wi‑Fi 6 in 2021 and Wi‑Fi 7 ESS patents in 2025.
- January 2024: Arix Bioscience share sale.
- Life Sciences portfolio monetization has produced substantial proceeds through December 31, 2025.
Summary
Acacia Research Corporation is a diversified holding company operating four primary business lines—Intellectual Property Licensing/Enforcement, Energy (via Benchmark), Industrial (Printronix), and Manufacturing (Deflecto)—plus a Life Sciences investment portfolio. The company emphasizes platform-building acquisitions, active operational oversight, and strategic use of capital. Acacia holds a majority interest in Benchmark (approximately 73.5%) and reported substantial IP licensing revenue (about $1.9 billion to date), with a large portion returned to patent partners. The company employed 986 full-time staff and 76 contractors as of December 31, 2025, and is controlled by Starboard Value LP, which shapes governance and capital strategy.
